Literature DB >> 16579967

JNK1 is required to preserve cardiac function in the early response to pressure overload.

Hideo Tachibana1, Cinzia Perrino, Hideyuki Takaoka, Roger J Davis, Sathyamangla V Naga Prasad, Howard A Rockman.   

Abstract

Cardiac stress consistently activates c-Jun NH(2)-terminal kinase (JNK) pathways, however the role of different members of the JNK family is unclear. In this study, we applied pressure overload (TAC) in mice with selective deletion of the three JNK genes (Jnk1(-/-), Jnk2(-/-), and Jnk3(-/-)). Following TAC, all three JNK knockout mouse lines developed cardiac hypertrophy similar to wild-type mice (WT), but only JNK1(-/-) mice displayed a significant reduction in fractional shortening after 3 and 7 days of pressure overload, associated with a significant increase in terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling staining and marked inflammatory infiltrate. After the acute deterioration stage, JNK1(-/-) mice underwent a slow recovery followed by a steady progression of cardiac dysfunction, becoming indistinguishable from WT after 12 weeks of TAC. These data suggest that JNK1 plays a protective role in response to pressure overload, preventing the early deterioration in cardiac function following an acute increase in afterload.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16579967     DOI: 10.1016/j.bbrc.2006.03.065

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 2.  Mitogen-activated protein kinases in heart development and diseases.

Authors:  Yibin Wang
Journal:  Circulation       Date:  2007-09-18       Impact factor: 29.690

3.  The deubiquitinase ubiquitin-specific protease 20 is a positive modulator of myocardial β1-adrenergic receptor expression and signaling.

Authors:  Samuel Mon-Wei Yu; Pierre-Yves Jean-Charles; Dennis M Abraham; Suneet Kaur; Clarice Gareri; Lan Mao; Howard A Rockman; Sudha K Shenoy
Journal:  J Biol Chem       Date:  2018-12-11       Impact factor: 5.157

4.  Cardiac fibrosis and miR-433.

Authors:  Jae Gyun Oh; Roger J Hajjar; Woo Jin Park
Journal:  Ann Transl Med       Date:  2016-12

5.  Caveolin and β1-integrin coordinate angiotensinogen expression in cardiac myocytes.

Authors:  Hind Lal; Suresh K Verma; Hao Feng; Honey B Golden; Fnu Gerilechaogetu; Damir Nizamutdinov; Donald M Foster; Shannon S Glaser; David E Dostal
Journal:  Int J Cardiol       Date:  2012-10-09       Impact factor: 4.164

Review 6.  Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

Authors:  Sabzali Javadov; Sehwan Jang; Bryan Agostini
Journal:  Pharmacol Ther       Date:  2014-06-09       Impact factor: 12.310

7.  The two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction.

Authors:  Dennis M Abraham; Teresa E Lee; Lewis J Watson; Lan Mao; Gurangad Chandok; Hong-Gang Wang; Stephan Frangakis; Geoffrey S Pitt; Svati H Shah; Matthew J Wolf; Howard A Rockman
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

8.  Stretch-induced regulation of angiotensinogen gene expression in cardiac myocytes and fibroblasts: opposing roles of JNK1/2 and p38alpha MAP kinases.

Authors:  Hind Lal; Suresh K Verma; Honey B Golden; Donald M Foster; Manuela Smith; David E Dostal
Journal:  J Mol Cell Cardiol       Date:  2008-09-26       Impact factor: 5.000

Review 9.  MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets.

Authors:  Anthony J Muslin
Journal:  Clin Sci (Lond)       Date:  2008-10       Impact factor: 6.124

10.  Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.

Authors:  Timothy D Calamaras; Robert A Baumgartner; Mark J Aronovitz; Angela L McLaughlin; Kelly Tam; Daniel A Richards; Craig W Cooper; Nathan Li; Wendy E Baur; Xiaoying Qiao; Guang-Rong Wang; Roger J Davis; Navin K Kapur; Richard H Karas; Robert M Blanton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-10-26       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.